Liver resections in metastatic gastric cancer
Authors:
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy aloneTrials, 2009
- Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancerAnti-Cancer Drugs, 2009
- Liver resection for metastatic gastric cancerEuropean Journal of Surgical Oncology, 2008
- Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastasesAnnals of Oncology, 2008
- Liver Resection for Metastatic Gastric Cancer: Experience with 42 Patients Including Eight Long-term SurvivorsJapanese Journal of Clinical Oncology, 2007
- Favorable indications for hepatectomy in patients with liver metastasis from gastric cancerJournal of Surgical Oncology, 2007
- Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinomaAnnals of Oncology, 2006
- Hepatic Resection for Noncolorectal Nonendocrine Liver MetastasesTransactions of the ... Meeting of the American Surgical Association, 2006
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factorsBritish Journal of Surgery, 1994